To the guy who said to me last year:
“What’s the big deal with rebranding? Just use some free online AI to choose a name and create a logo!”
Here’s (part of) the answer: https://t.co/tg4XY8aOj6
#Rebranding#Communications#InvestorRelations#Strategy#Marketing
We're very pleased to announce promising results for our anti-IL-17 NanoAb as an innovative psoriasis treatment
Details here > https://t.co/EPp0Mq5gdM
$SCNI #psoriasis#nanobody#antibody#NanoAb#treatment
Thank you to Ohad Lavi, CEO of Voyager Medical Research, for choosing Scinai Bioservices as your CDMO!
https://t.co/FtcskVx5Gq
Limited availability for 2024 - Contact [email protected] for info today!
Good news! Thanks to @InnovationAut for their support and belief in Scinai's exciting potential!
The IAA approved a grant covering 66% of a ₪3.5m (~US$900K) project for our new CDMO business unit.
Details > https://t.co/PQbU6byUFC
$SCNI #CDMO#IsraelInnovation 🇮🇱
Scinai’s #CDMO offers upstream and downstream process development and scale-up for protein-based drugs, analytical method development, and cGMP manufacturing including aseptic filling to biopharmaceutical and biotech clients.
Meet us @CPHI_Events via [email protected]
We're excited to share today encouraging results in a preclinical study of our anti‑interleukin 17 (IL‑17) NanoAbs as a treatment for plaque psoriasis.
https://t.co/gHnHuqWdx1
$SCNI #NanoAb#Psoriasis#Scinai#Immunotherapeutics
@AriZoldan@Nasdaq Great to meet you last week in Basel, Ari. And thanks for including @BiondVax's story in your summary of the conference: https://t.co/6MnzKAjeZj
[EXCITING NEW RESULTS] COVID-19 illness was virtually prevented in hamsters administered BiondVax’s inhaled NanoAb and infected three hours later with SARS-CoV-2
Details > https://t.co/hPskNXM8iK
#COVID19#Protection#Prophylactic $BVXV #BVXV
BiondVax’s Innovative Inhaled COVID-19 Therapy Virtually Eliminated SARS-COV-2 Virus in Preclinical In Vivo Study
https://t.co/eG1YwqaHuZ
$BVXV #BiondVax
@maxplanckpress@MPI_EVA_Leipzig Congrats @maxplanckpress for your 3rd Nobel Prize in the past 2 years!
The awards testify to your world-leading quality of research and innovation; We are proud to be closely collaborating with @mpi_nat scientists for development of innovative nanosized antibody therapies.